These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 23496911)
1. Quantitative assessment of the associations between XRCC1 polymorphisms and bladder cancer risk. Mao Y; Xu X; Lin Y; Chen H; Wu J; Hu Z; Zhu Y; Xu X; Xie L World J Surg Oncol; 2013 Mar; 11():58. PubMed ID: 23496911 [TBL] [Abstract][Full Text] [Related]
2. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis. Xie T; Wang ZG; Zhang JL; Liu H World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255 [TBL] [Abstract][Full Text] [Related]
3. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis. Li Y; Liu F; Tan SQ; Wang Y; Li SW PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511 [TBL] [Abstract][Full Text] [Related]
4. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis. Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981 [TBL] [Abstract][Full Text] [Related]
5. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis. Zhou X; Gu L; Zeng Y; Wei L; Ying M; Wang N; Su C; Wang Y; Liu C Tumour Biol; 2014 Nov; 35(11):10665-76. PubMed ID: 25062722 [TBL] [Abstract][Full Text] [Related]
6. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis. Xue H; Ni P; Lin B; Xu H; Huang G Am J Epidemiol; 2011 Feb; 173(4):363-75. PubMed ID: 21216841 [TBL] [Abstract][Full Text] [Related]
7. XRCC1 polymorphisms increase bladder cancer risk in Asians: a meta-analysis. Zhang F; Wu JH; Zhao W; Liu HT Tumour Biol; 2013 Oct; 34(5):2659-64. PubMed ID: 23636799 [TBL] [Abstract][Full Text] [Related]
8. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis. Ma WQ; Han XQ; Wang X; Wang Y; Zhu Y; Liu NF PLoS One; 2016; 11(11):e0166961. PubMed ID: 27870881 [TBL] [Abstract][Full Text] [Related]
9. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: a meta-analysis. Du Y; Han LY; Li DD; Liu H; Gao YH; Sun DJ Asian Pac J Cancer Prev; 2013; 14(9):5483-7. PubMed ID: 24175846 [TBL] [Abstract][Full Text] [Related]
10. XRCC1 Arg194Trp and Arg280His polymorphisms increase bladder cancer risk in Asian population: evidence from a meta-analysis. Fang Z; Chen F; Wang X; Yi S; Chen W; Ye G PLoS One; 2013; 8(5):e64001. PubMed ID: 23704969 [TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of an association between the XRCC1 polymorphisms and gliomas risk. Li M; Zhou Q; Tu C; Jiang Y J Neurooncol; 2013 Feb; 111(3):221-8. PubMed ID: 23238971 [TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies. Zhang H; Liu H; Jiang G PLoS One; 2013; 8(11):e80687. PubMed ID: 24363792 [TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of the association between XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of cutaneous melanoma. Jiang H; Xu W; Zhang F; Wei L; Wang Y; Wang Y; Liu C Melanoma Res; 2016 Jun; 26(3):290-9. PubMed ID: 26967970 [TBL] [Abstract][Full Text] [Related]
14. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population. Yang HY; Yang SY; Shao FY; Wang HY; Wang YD Asian Pac J Cancer Prev; 2015; 16(2):495-500. PubMed ID: 25684477 [TBL] [Abstract][Full Text] [Related]
15. XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis. Wei B; Zhou Y; Xu Z; Ruan J; Zhu M; Jin K; Zhou D; Hu Q; Wang Q; Wang Z; Yan Z Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):225-31. PubMed ID: 21647176 [TBL] [Abstract][Full Text] [Related]
16. No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis. Li C; Xiang X; Zhou Y Mol Biol Rep; 2014 Nov; 41(11):7613-21. PubMed ID: 25086624 [TBL] [Abstract][Full Text] [Related]
17. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis. Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739 [TBL] [Abstract][Full Text] [Related]
18. XRCC1 Gene Polymorphisms and Breast Cancer Risk: A Systematic Review and Meta- Analysis Study. Sanjari Moghaddam A; Nazarzadeh M; Sanjari Moghaddam H; Bidel Z; Keramatinia A; Darvish H; Mosavi-Jarrahi A Asian Pac J Cancer Prev; 2016; 17(S3):323-30. PubMed ID: 27165246 [TBL] [Abstract][Full Text] [Related]
19. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis. Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463 [TBL] [Abstract][Full Text] [Related]
20. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis. Zhang H; Liu H; Knauss JL Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]